Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$393,692,080
+$75,026,590 QoQ
Shares Held
2,335,897
-3.4% QoQ
Ownership
2.30%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#8
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $393,692,080 | 2,335,897 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $318,665,490 | 2,418,897 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $317,528,578 | 2,238,797 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $339,480,532 | 2,418,297 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $297,432,438 | 2,366,397 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $276,798,288 | 2,502,697 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $339,802,690 | 2,489,397 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $296,639,190 | 2,574,546 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $339,789,659 | 2,468,146 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $310,547,016 | 2,251,646 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $262,010,820 | 1,988,546 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $178,893,450 | 1,590,164 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $154,972,808 | 1,643,402 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $197,081,818 | 1,947,064 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $192,736,028 | 1,613,664 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $153,204,101 | 1,442,464 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $141,250,762 | 1,449,023 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $120,011,531 | 1,280,123 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $121,253,462 | 1,423,664 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $130,050,507 | 1,355,964 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $120,941,802 | 1,242,723 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $135,942,274 | 1,397,864 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $173,219,257 | 1,807,191 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $206,692,458 | 2,149,464 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $181,141,208 | 1,484,764 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $62,262,512 | 719,382 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||